This is consistent with the previous reports, which showed that the inhibition of ERK1/2 and/or PI3 K/Akt pathways by apigenin plays an important role in its inhibiting effects on VEGF expression in various malignant tumors [12–14, 17, 21]. The gene discussed is VEGFA; the disease is cancer.